On top of that, about 70% of people getting NAD+ IV therapy see a 3-10 fold increase in high-sensitivity C-reactive protein (hs-CRP)
If left untreated, the deficiency can cause severe neurologic problems and blood diseases
Conversely, stress conditions inhibit mTOR, triggering autophagy and metabolic reprogramming that sensitize cells to ferroptosis
While DSIP was described as 'adaptogenic' and stress-protective in older animal work, robust human data demonstrating a cortisol-lowering effect are lacking, and claims of a defined anti-stress action should be treated cautiously
Their solutions meet high standards, ensuring accurate peptide reconstitution and safe injections every time
A decrease in oxygen supply, resulting in hypoxia is also strongly connected with breakdown of the BBB, resulting in increased oxidative stress and permeability